Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial An accurate risk model is critical for risk-stratified cancer care and ...
An artificial intelligence (AI)-based method developed by researchers from Massachusetts General Hospital (MGH) can help identify early-stage melanoma patients at risk for cancer recurrence and assist ...
Researchers have developed and validated a machine learning--based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence. Most deaths from ...
Penn Medicine researchers discover method to identify, prevent recurrence in breast cancer survivors
Researchers at Penn’s Abramson Cancer Center and Perelman School of Medicine recently discovered how to find and treat dormant cancer cells to help identify — and prevent recurrence in breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results